C5F2-HCB
C5F2-HCB is a CYP-mediated inhibitor of the biosynthesis of arachidonic acid epoxygenase product (±) 14,15-EET (HY-150084), with an IC50 of 3.1 μM. C5F2-HCB inhibits EET-driven oxidative phosphorylation (OXPHOS) associated with tumor hypoxia, converting an immunologically "cold" tumor microenvironment into a "hot" one. C5F2-HCB reverses the immune-excluded tumor microenvironment in ER+HER2− breast cancer allograft models. C5F2-HCB can be used in research related to ER+HER2− breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 2792206-44-9
- Formula: C17H25F2N5
- Molecular Weight:337.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2792206-44-9
-
Molecular Weight 337.41
-
Formula C17H25F2N5
-
SMILES
N=C(NC(NCCCCC(F)(F)C)=N)NCC12[C@H]3[C@H]4[C@@H]1[C@@H]5C4[C@H]3[C@@H]52
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Oxidative Phosphorylation: Cancer & Beyond Therapeutic Target
Oxidative phosphorylation (OXPHOS) is the mitochondrial energy-conversion process in which the electron transport chain uses reducing equivalents from NADH and FADH2 to generate a proton gradient that drives ATP synthase.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)